DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Halozyme Therapeutics
HALO
Teradata Corp
TDC
Cars.com
CARS
Collegium Pharmaceutical
COLL
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -975.89%-20.93M | 2,505.43%16.38M | 364.94%22.85M | 112.89%4.16M | 379.95%11.08M | 149.61%2.39M | 66.47%-681K | 59.82%-8.62M | -52.60%-32.26M | -3.96M |
Net income from continuing operations | -19.03%-22.73M | 37.99%-10.88M | 63.39%-9.61M | 19.13%-73.42M | 57.82%-10.53M | 43.81%-19.1M | -28.32%-17.54M | -44.40%-26.26M | 3.42%-90.79M | ---24.95M |
Operating gains losses | 716.86%6.95M | -128.27%-767K | -133.96%-3.25M | -57.41%7.33M | -240.99%-3.83M | -108.94%-1.13M | 150.28%2.71M | 1,113.71%9.56M | 1,018.14%17.2M | --2.71M |
Depreciation and amortization | 87.60%15.9M | 115.36%14.38M | 169.93%15.34M | 321.10%29.35M | 63.83%8.52M | 454.88%8.47M | 2,671.37%6.68M | 141,975.00%5.68M | --6.97M | --5.2M |
Deferred tax | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 58.37%-256K | --0 |
Other non cash items | -283.96%-26.68M | 15.55%10.54M | 415.69%20.45M | 131.20%42.61M | 140.26%15.03M | 167.60%14.5M | 466.34%9.12M | -22.96%3.97M | -70.56%18.43M | --6.26M |
Change In working capital | 241.98%3.83M | 40.05%-2.44M | -84.42%-5.68M | -180.60%-10.61M | -113.85%-767K | -129.34%-2.69M | -153.07%-4.07M | 66.58%-3.08M | 40.82%13.16M | --5.54M |
-Change in receivables | 32.83%-1.83M | ---886K | ---667K | -222.82%-1M | --1.72M | ---2.72M | --0 | --0 | 225.97%815K | --0 |
-Change in prepaid assets | -121.67%-241K | 23.95%1.12M | -20.92%567K | 115.41%555K | 8.52%-2.18M | -32.44%1.11M | -42.84%906K | 116.12%717K | -141.84%-3.6M | ---2.38M |
-Change in payables and accrued expense | 355.69%6.04M | 23.59%-3.03M | -59.50%-5.53M | -160.76%-10.22M | -106.05%-421K | -129.45%-2.36M | -162.35%-3.97M | 23.62%-3.46M | 44.39%16.81M | --6.96M |
-Change in other current assets | -110.46%-135K | 136.98%368K | 86.11%-45K | 109.13%95K | -87.29%123K | 281.07%1.29M | -129.79%-995K | 62.41%-324K | -530.30%-1.04M | --968K |
-Change in other current liabilities | -9.09%-12K | -10.00%-11K | -20.00%-12K | -124.00%-42K | -10.00%-11K | -104.85%-11K | 52.38%-10K | 52.38%-10K | 4,275.00%175K | ---10K |
Cash from discontinued investing activities | 0 | 0 | 0 | 105.71%103K | 64.07%-180K | 99.13%-11K | 7,580.00%384K | -80.00%-90K | 39.01%-1.8M | -501K |
Operating cash flow | -979.94%-20.93M | 5,615.49%16.38M | 362.21%22.85M | 112.51%4.26M | 344.45%10.9M | 139.15%2.38M | 85.34%-297K | 59.49%-8.71M | -41.36%-34.07M | ---4.46M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 144.02%11.18M | -609.93%-46.6M | -282.85%-46.98M | 17.05%-78.01M | -116.82%-33.78M | -836.50%-25.4M | 84.13%-6.56M | 69.75%-12.27M | 47.08%-94.05M | -15.58M |
Net PPE purchase and sale | 18.40%-20.73M | -676.15%-46.6M | -370.45%-46.98M | -22.94%-75.17M | -371.14%-33.78M | -201.65%-25.4M | 75.05%-6M | 53.53%-9.99M | 16.84%-61.14M | ---7.17M |
Net business purchase and sale | --0 | --0 | --0 | 93.84%-2.85M | --0 | --0 | 96.76%-560K | 88.02%-2.29M | 55.69%-46.17M | ---8.18M |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --13.27M | ---234K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 144.02%11.18M | -609.93%-46.6M | -282.85%-46.98M | 17.05%-78.01M | -116.82%-33.78M | -836.50%-25.4M | 84.13%-6.56M | 69.75%-12.27M | 47.08%-94.05M | ---15.58M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -429.45%-70.43M | 4,797.66%88.5M | -47.66%15.52M | 33.21%119.87M | 325.36%70.73M | 59.13%21.38M | -104.63%-1.88M | 54.41%29.65M | -62.81%89.98M | 16.63M |
Net issuance payments of debt | ---75.83M | ---30.16M | -2,772.96%-33.41M | -121.17%-5.35M | -323.56%-6.6M | --0 | --0 | --1.25M | -78.63%25.27M | ---1.56M |
Net common stock issuance | -28.15%15.48M | 2,269.27%122.52M | 63.87%50.72M | 187.19%135.92M | 645.41%78.25M | 682.46%21.54M | -81.05%5.17M | 356.05%30.95M | -36.37%47.33M | --10.5M |
Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -80.60%9.57M | --0 |
Proceeds from stock option exercised by employees | --2.29M | --1.9M | --0 | -56.14%2.5M | --0 | --0 | --0 | --2.5M | --5.7M | --5.7M |
Net other financing activities | -7,486.50%-12.37M | 18.41%-5.76M | 64.55%-1.79M | -723.62%-13.2M | -146.75%-929K | 88.75%-163K | -349.94%-7.06M | -260.63%-5.06M | --2.12M | --1.99M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -429.45%-70.43M | 4,797.66%88.5M | -47.66%15.52M | 33.21%119.87M | 325.36%70.73M | 59.13%21.38M | -104.63%-1.88M | 54.41%29.65M | -62.81%89.98M | --16.63M |
Net cash flow | ||||||||||
Beginning cash position | 1,163.31%104.11M | 169.78%45.82M | 554.08%54.44M | -82.08%8.32M | -43.78%6.6M | 793.82%8.24M | 373.68%16.99M | -82.08%8.32M | 637.38%46.46M | --11.73M |
Current changes in cash | -4,770.66%-80.17M | 766.50%58.29M | -199.45%-8.62M | 220.94%46.12M | 1,503.87%47.84M | -115.23%-1.65M | -228.27%-8.75M | 120.21%8.66M | -194.96%-38.13M | ---3.41M |
End cash Position | 262.97%23.94M | 1,163.31%104.11M | 169.78%45.82M | 554.08%54.44M | 554.08%54.44M | -43.78%6.6M | 793.82%8.24M | 373.68%16.99M | -82.08%8.32M | --8.32M |
Free cash flow | -80.91%-41.65M | -379.59%-30.22M | -29.06%-24.13M | 33.69%-70.91M | -96.81%-22.88M | -56.94%-23.02M | 75.98%-6.3M | 65.63%-18.7M | 35.40%-106.92M | ---11.63M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |